Poolbeg Pharma PLC (AIM: POLB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
7.20
+0.02 (0.28%)
Dec 19, 2024, 4:27 PM GMT+1

Poolbeg Pharma Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
4.093.383.062.71
Research & Development
1.511.682.20.55
Other Operating Expenses
-0.48-0.37-0.28-0.15
Operating Expenses
5.134.694.993.11
Operating Income
-5.13-4.69-4.99-3.11
Interest & Investment Income
0.510.530.21-
EBT Excluding Unusual Items
-4.62-4.15-4.78-3.11
Asset Writedown
-0.35-0.35--
Pretax Income
-4.98-4.51-4.78-3.11
Income Tax Expense
-0.6-0.57-0.09-
Net Income
-4.38-3.93-4.69-3.11
Net Income to Common
-4.38-3.93-4.69-3.11
Shares Outstanding (Basic)
500500500317
Shares Outstanding (Diluted)
500500500317
Shares Change (YoY)
--57.62%-
EPS (Basic)
-0.01-0.01-0.01-0.01
EPS (Diluted)
-0.01-0.01-0.01-0.01
Free Cash Flow
-4.36-4.38-4.37-2.86
Free Cash Flow Per Share
-0.01-0.01-0.01-0.01
EBITDA
-5.11-4.66-4.96-3.09
D&A For EBITDA
0.030.030.030.02
EBIT
-5.13-4.69-4.99-3.11
Source: S&P Capital IQ. Standard template. Financial Sources.